+0%

est. 2Y upside i

HealthcareSeries A

Real-World Data for Health Innovation

Rank

#2025

Sector

Healthcare Technology

Est. Liquidity

~4Y

Data Quality

Data: Low

Equity upside is highly uncertain due to missing valuation and growth data.

Last updated: July 3, 2026

Bull (9%)+115%

Exit multiple expands to 10x on IPO window and category leadership; projected revenue $12.2M yields exit value $122M, 2.3x entry before dilution.

Base (50%)+21%

Multiple converges to 6x, in line with public comps; exit value $73.2M, 1.4x entry before dilution, but 20% dilution reduces net upside.

Bear (41%)-50%

Multiple compresses to 3x due to big tech competition; exit value $36.6M below entry, with dilution and preference overhang further eroding common value.

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

3900%

Total funding $20.3M implies a 39% preference overhang on the implied $52M valuation, meaning common stock faces substantial pre-money risk.

Dilution Risk

high

With no disclosed cash runway and moderate capital intensity, a further raise within 12-18 months is likely, diluting common by ~20%.

Secondary Liquidity

none

No secondary market transactions have been identified; employee equity is illiquid until a liquidity event.

Other — 1 role

View all 1 open roles at Segmed →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Segmed's data — designed to show you've done your homework.

  • 1

    “How does Segmed differentiate its platform from Truveta and big tech healthcare cloud offerings?”

  • 2

    “What is the revenue mix between SaaS subscriptions and data licensing, and how does that affect margin scalability?”

  • 3

    “What is the current option pool size and strike price relative to the latest round valuation?”

Community

Valuation Sentiment

Our model estimates +0% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.